Insight Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Insight Wealth Partners's ABBV Position: Q3 2026 in Review
Insight Wealth Partners increased its AbbVie (ABBV) stake by 0.54% in Q3 2026, buying an estimated $2.82K and bringing the position to 2,049 shares worth $536K. The position accounts for 0.07% of the portfolio, ranked #85.
Insight Wealth Partners first reported a position in ABBV in Q1 2023 and has held it in 15 quarters since. The position peaked at $918K in Q1 2023. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Insight Wealth Partners held 2,049 shares of AbbVie worth $536K as of Q3 2026.
- Insight Wealth Partners bought 11 AbbVie shares in Q3 2026, an estimated $2.82K.
- AbbVie made up 0.07% of Insight Wealth Partners's portfolio in Q3 2026, its #85 holding.
- Insight Wealth Partners first reported a position in AbbVie in Q1 2023 and has held it in 15 quarters since.
- Insight Wealth Partners's AbbVie position peaked at $918K in Q1 2023.
- 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Insight Wealth Partners's 13F filing for Q3 2026, filed 26 Oct 2026.